NASHVILLE, Tenn., March 5, 2013 /PRNewswire/ -- NextGxDx Inc., which provides an online genetic testing marketplace for healthcare professionals and hospitals, today announced the successful closing of a $1 million, angel-funded, convertible note round. The company's capital goal was fully met with the Series A2 financing, with NextGxDx welcoming several new investors alongside existing shareholders as participants.
NextGxDx will use the new capital to increase brand awareness, accelerate the growth of its healthcare professional user base, and expand the company's laboratory relationships. The funding will also allow the company to expand its staff to support these initiatives.
"The angel investor community has embraced the NextGxDx mission of adding transparency and access to information in the confusing world of genetic testing," said Mark Harris, Ph.D., CEO of NextGxDx. "As hospitals and healthcare professionals have responded, the company is experiencing a surge in momentum that includes the addition of physician research organizations and high-quality genetic reference labs as partners in this endeavor."
NextGxDx will unveil new features and functionality at the American Academy of Neurology Annual Meeting in San Diego March 16–23 and the American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting in Phoenix March 19–23.
"Through our cloud-based solution, NextGxDx delivers a unique efficiency and cost savings advantage to its customers and partners," said Julia Polk, acting chief financial officer of NextGxDx. "The investor community clearly understands the value proposition we bring to physicians, genetic counselors and staff members needing a better way to research and order tests, and manage results."
NextGxDx provides an online genetic testing marketplace that offers healthcare professionals and hospitals the ability to access up-to-date listings of all genetic tests from CLIA-certified laboratories, view pertinent information about each test, order tests online, and manage results electronically within the HIPAA-compliant portal. By providing clinicians with a one-stop-shop to search, compare and order genetic tests, NextGxDx reduces the time and costs associated with the ordering of genetic tests. For more information, visit www.NextGxDx.com.